Biomerica Inc.

3.05-0.0700-2.24%Vol 32.82K1Y Perf -22.39%
Aug 11th, 2022 16:00 DELAYED
BID2.91 ASK3.11
Open3.12 Previous Close3.12
Pre-Market- After-Market3.05
 - -  - -%
Target Price
13.00 
Analyst Rating
— 0.00
Potential %
326.23 
Finscreener Ranking
★★★★+     57.79
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     43.51
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     52.11
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
10.16 
Earnings Rating
Neutral
Market Cap39.20M 
Earnings Date
26th Aug 2022
Alpha0.03 Standard Deviation0.26
Beta-0.33 

Today's Price Range

3.023.20

52W Range

2.567.38

5 Year PE Ratio Range

-20.90-16.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-4.09%
1 Month
1.67%
3 Months
12.96%
6 Months
-33.55%
1 Year
-22.39%
3 Years
-10.56%
5 Years
12.13%
10 Years
362.12%

TickerPriceChg.Chg.%
BMRA3.05-0.0700-2.24
AAPL168.49-0.7500-0.44
GOOG119.82-0.8300-0.69
MSFT287.02-2.1400-0.74
XOM93.192.62002.89
WFC45.250.92002.08
JNJ167.14-3.5300-2.07
FB196.640.99000.51
GE78.901.76002.28
JPM120.141.75001.48
 
ProfitabilityValueIndustryS&P 500US Markets
17.10
-23.60
-20.90
-82.70
-20.43
RevenueValueIndustryS&P 500US Markets
13.57M
1.06
28.45
13.28
Earnings HistoryEstimateReportedSurprise %
Q03 2022-0.10-0.0190.00
Q02 2022-0.08-0.09-12.50
Q01 2022-0.12-0.120.00
Q04 2021-0.10-0.12-20.00
Q03 2021-0.02-0.15-650.00
Q02 2021-0.10-0.13-30.00
Q01 2021-0.09-0.14-55.56
Q04 2020-0.06-0.0433.33
Earnings Per EndEstimateRevision %Trend
5/2021 QR-0.03-200.00Negative
2/2022 QR-0.1074.36Positive
5/2022 FY-0.430.00-
5/2023 FY0.040.00-
Next Report Date26th Aug 2022
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume32.82K
Shares Outstanding12.85K
Shares Float11.49M
Trades Count208
Dollar Volume101.34K
Avg. Volume369.82K
Avg. Weekly Volume47.74K
Avg. Monthly Volume766.68K
Avg. Quarterly Volume295.04K

Biomerica Inc. (NASDAQ: BMRA) stock closed at 3.05 per share at the end of the most recent trading day (a -2.24% change compared to the prior day closing price) with a volume of 32.82K shares and market capitalization of 39.20M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 45 people. Biomerica Inc. CEO is Zackary S. Irani.

The one-year performance of Biomerica Inc. stock is -22.39%, while year-to-date (YTD) performance is -21.59%. BMRA stock has a five-year performance of 12.13%. Its 52-week range is between 2.5601 and 7.38, which gives BMRA stock a 52-week price range ratio of 10.16%

Biomerica Inc. currently has a PE ratio of -10.80, a price-to-book (PB) ratio of 3.83, a price-to-sale (PS) ratio of 2.57, a price to cashflow ratio of 13.20, a PEG ratio of 2.32, a ROA of -22.69%, a ROC of -29.93% and a ROE of -34.44%. The company’s profit margin is -20.43%, its EBITDA margin is -20.90%, and its revenue ttm is $13.57 Million , which makes it $1.06 revenue per share.

Of the last four earnings reports from Biomerica Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Biomerica Inc.’s next earnings report date is 26th Aug 2022.

The consensus rating of Wall Street analysts for Biomerica Inc. is (0), with a target price of $13, which is +326.23% compared to the current price. The earnings rating for Biomerica Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biomerica Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biomerica Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 21.70, ATR14 : 0.19, CCI20 : 76.90, Chaikin Money Flow : -0.84, MACD : 0.03, Money Flow Index : 70.76, ROC : 15.99, RSI : 48.96, STOCH (14,3) : 69.23, STOCH RSI : 0.64, UO : 57.39, Williams %R : -30.77), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biomerica Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
1 (100.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Moderate Buy
2.00

Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market.

CEO: Zackary S. Irani

Telephone: +1 949 645-2111

Address: 17571 Von Karman Avenue, Irvine 92614, CA, US

Number of employees: 45

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

56%44%

Bearish Bullish

61%39%


News

Stocktwits